Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Bariatric surgery is associated with long-term remission of type 2 diabetes

This week's Journal of the American Medical Association examines the association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.

News image

Short-term studies show that bariatric surgery causes remission of diabetes.

The long-term outcomes for remission and diabetes-related complications are not known.

Dr Lars Sjöström and colleagues determined the long-term diabetes remission rates, and the cumulative incidence of microvascular and macrovascular diabetes complications after bariatric surgery.

The Swedish Obese Subjects (SOS) is a prospective matched cohort study conducted at 25 surgical departments and 480 primary health care centers in Sweden.

Of patients recruited between 1987 and 2001, 260 of 2037 control patients and 343 of 2010 surgery patients had type 2 diabetes at baseline.

For the current analysis, diabetes status was determined at SOS health examinations until 2013.

The diabetes remission rate 2 years after surgery was 72% for bariatric surgery patients
Journal of the American Medical Association

Information on diabetes complications was obtained from national health registers until 2012.

Participation rates at the 2-, 10-, and 15-year examinations were 81%, 58%, and 41% in the control group, and 90%, 76%, and 47% in the surgery group.

For diabetes assessment, the team found that the median follow-up time was 10 years and 10 years in the control and surgery groups, respectively.

For diabetes complications, team noted that the median follow-up time was 17 years, and 18 years in the control and surgery groups, respectively.

Adjustable or nonadjustable banding, vertical banded gastroplasty, or gastric bypass procedures were performed in the surgery group, and usual obesity and diabetes care was provided to the control group.

The team's main outcome measures included diabetes remission, relapse, and diabetes complications.

Remission was defined as blood glucose <110 mg/dL and no diabetes medication.

The diabetes remission rate 2 years after surgery was 16% for control patients, and 72% for bariatric surgery patients.

At 15 years, the team noted that diabetes remission rates decreased to 7% for control patients, and to 30% for bariatric surgery patients.

With long-term follow-up, the cumulative incidence of microvascular complications was 42 per 1000 person-years for control patients, and 21 per 1000 person-years in the surgery group.

The research team observed macrovascular complications in 44 per 1000 person-years in control patients, and 32 per 1000 person-years for the surgical group.

Dr Sjöström's team comments, "In this very long-term follow-up observational study of obese patients with type 2 diabetes, bariatric surgery was associated with more frequent diabetes remission and fewer complications than usual care."

"These findings require confirmation in randomized trials."

JAMA 2014;311(22):2297-2304
12 June 2014

Go to top of page Email this page Email this page to a colleague

 06 May 2015

Advanced search
 06 May 2015 
Infant feeding and celiac disease
 06 May 2015 
Preventing recurrent C. diff infection
 06 May 2015 
PPIs and spontaneous bacterial peritonitis
 05 May 2015 
Prevalence of eosinophilic esophagitis
 05 May 2015 
Fatigue in primary sclerosing cholangitis
 05 May 2015 
Annual CT scans after esophagectomy for cancer
 04 May 2015 
Stress resilience and peptic ulcer disease
 04 May 2015 
Menarche and NAFLD
 04 May 2015 
Endoscope storage and microbial colonization
 01 May 2015 
Sleep and physical activity measured in Crohn's
 01 May 2015 
NAFLD progression from steatosis to fibrosing-steatohepatitis
 01 May 2015 
Dietary supplement hepatotoxicity
 30 April 2015 
Botulinum toxin A for the treatment of obesity
 30 April 2015 
Neoadjuvant chemoradiotherapy for esophageal cancer
 30 April 2015 
Risk factors for primary sclerosing cholangitis
 29 April 2015 
Liver enzyme elevations after anti-TNF therapy in IBD

 29 April 2015 
Hepatocellular carcinoma surveillance in HBV
 29 April 2015 
Response to sorafenib in hepatocellular carcinoma
 28 April 2015 
Risk factors of hepatocellular carcinoma
 28 April 2015 
Clinical outcomes after esophagectomy
 28 April 2015 
Alcohol drinking and risk of liver cirrhosis
 23 April 2015 
Gut microbiota modulation for alcoholic liver disease
 23 April 2015 
Moderate sodium restriction diet in cirrhosis
 23 April 2015 
Gastroesophageal junction disruption and obesity
 22 April 2015 
Hepatitis and mortality in hospitalized patients
 22 April 2015 
Magnetic sphincter augmentation for GERD
 22 April 2015 
Drug, herbal and dietary supplement hepatotoxicity
 21 April 2015 
Risk factors of postpartum bowel changes
 21 April 2015 
Tracking colonoscopy surveillance intervals
 21 April 2015 
PPI increases risk of cryptogenic liver abscess
 20 April 2015 
IBS after traveller's diarhea
 20 April 2015 
Economic impact of C. diff infection
 20 April 2015 
Adherence to Hep C treatments
 17 April 2015 
Synchronous colorectal advanced neoplasia
 17 April 2015 
PNPLA3 polymorphisms and NAFLD risk
 17 April 2015 
MELD score and colorectal resection
 16 April 2015 
Bleeding risk in colonic diverticulosis
 16 April 2015 
Minority use of high-volume hospitals for colorectal cancer
 16 April 2015 
Sleep and IBD
 15 April 2015 
Treatment of hepatocellular carcinoma
 15 April 2015 
Score predicts malignant bile duct obstruction
 15 April 2015 
Increased risk of Barrett esophagus
 14 April 2015 
Improving colorectal cancer screening uptake
 14 April 2015 
Colorectal cancer presenting under the age of 50
 14 April 2015 
Functional constipation vs constipation predominant IBS
 13 April 2015 
Fecal transplant for C. difficile
 13 April 2015 
Immune based treatments for HCC
 13 April 2015 
CRP and acute diverticulitis
 10 April 2015 
Hypnotherapy for IBS
 10 April 2015 
Adjuvant therapy after rectal cancer
 10 April 2015 
Viral outcomes in HCV infection
 09 April 2015 
Male IBD patients wishing to conceive
 09 April 2015 
Screening programs based on the fecal immunochemical test
 09 April 2015 
Management of esophageal food impaction
 08 April 2015 
Nonceliac gluten sensitivity
 08 April 2015 
Ambulatory hemorrhoidal surgery
 08 April 2015 
Iron fortification and gut inflammation
 07 April 2015 
Treatment of Hep C virus
 07 April 2015 
Interventions for eosinophilic esophagitis
 07 April 2015 
Endoscopic managements of GI bleeds

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us